Efficacy and Safety of Prepopik® in Children for Overall Colon Cleansing in Preparation for Colonoscopy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

June 3, 2014

Primary Completion Date

February 15, 2017

Study Completion Date

March 16, 2017

Conditions
Need for Bowel Preparation
Interventions
DRUG

Prepopik® ½ Sachet x 2 (9-12 years)

DRUG

Prepopik® 1 Sachet x 2 (9-12 years)

DRUG

Oral polyethylene glycol (PEG) based preparation (9-12 years)

DRUG

Prepopik® 1 Sachet x 2 (13-16 years)

DRUG

Oral polyethylene glycol (PEG) based preparation (13-16 years)

Trial Locations (9)

Unknown

University of Alabama, Birmingham

University California San Diego - Rady's Children's Hospital, San Diego

IU Medical Center / Riley Hospital, Indianapolis

John Hopkins, Baltimore

Stony Brook Children's, Stony Brook

Nationwide Children's Hospital, Columbus

Children's Hospital of Philadelphia, Philadelphia

Children's Hospital of Pittsburgh, Pittsburgh

Vanderbilt University Medical Center, Nashville

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY

NCT01928862 - Efficacy and Safety of Prepopik® in Children for Overall Colon Cleansing in Preparation for Colonoscopy | Biotech Hunter | Biotech Hunter